deltatrials
Completed PHASE4 INTERVENTIONAL 4-arm NCT00669643

Uniform Multidrug Therapy Regimen for Leprosy Patients (U-MDT)

Independent Study to Establish the Efficacy of the Six Doses Uniform MDT Regimen (U-MDT) for Leprosy Patients

Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico

Conditions Leprosy
Interventions MB 12 doses - Rifampicin, Clofazimine and Dapsone MB 6 doses - Rifampicin, Clofazimine and Dapsone PB 6 doses - Rifampicin and Dapsone PB 6 doses - Rifampicin, Clofazimine and Dapsone
Updated 6 times since 2017 Last updated: May 31, 2017 Started: Feb 28, 2007 Primary completion: Sep 30, 2012 Completion: Dec 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Leprosy, this trial is completed. The trial is conducted by Conselho Nacional de Desenvolvimento Científico e Tecnológico and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshotActive Not Recruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jun 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE4

    First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Alfredo da Matta, Manaus, Brazil
  • Instituto de Dermatologia Dona Libania, Fortaleza, Brazil
  • Ministry of Health, Brazil
  • Ministry of Science and Technology, Brazil
  • University of Brasilia
Data source: University of Brasilia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations